Target intelligence / Profile preview

ribosomal protein L34 pseudogene 33 (RPL34P33)

Target: RPL34P33
Molecular classification: Other (Pseudogene)

Overview

RPL34P33 (ribosomal protein L34 pseudogene 33) is a processed pseudogene, meaning it is a genetic element related to the ribosomal protein L34 gene but does not encode a functional protein[5]. Like other processed pseudogenes, it is an inactive DNA sequence resulting from retrotransposition of mRNA from its parent gene. It is not itself translated or transcribed into a functional therapeutic target. There is no current evidence supporting its role as a disease gene, receptor, enzyme, or biomarker. Information for this pseudogene in major genomic or protein databases is extremely limited, reflecting a lack of biological function and clinical relevance[5].

Other names: RPL34_18_1640

Beyond the preview

Go deeper on ribosomal protein L34 pseudogene 33 (RPL34P33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L34 pseudogene 33 (RPL34P33).

Explore the full profile